Research Topics
| John IskanderSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
| Collaborators
|
Detail Information
Publications
Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experienceJohn Iskander
US Public Health Service, Immunization Safety Office, Office of Chief Science Officer, Centers for Disease Control and Prevention, 1600 Clifton Road, MS D 26, Atlanta, GA 30333, USA
Expert Rev Vaccines 7:75-82. 2008..Thus, the challenge of influenza vaccine safety is to detect new safety concerns that may arise during seasonal campaigns, while preparing vaccine safety systems for the timely detection of adverse events in the setting of a pandemic...
Data mining in the US using the Vaccine Adverse Event Reporting SystemJohn Iskander
Office of Immunization Safety, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Drug Saf 29:375-84. 2006..Such approaches are needed as more new vaccines continue to be licensed...
Monitoring vaccine safety during an influenza pandemicJohn Iskander
Immunization Safety Office, Office of the Chief Science Officer, Office of the Director, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Yale J Biol Med 78:265-75. 2005..Advance planning and the use of available technologic solutions are needed to respond to the scientific and logistic challenges involved in safely implementing mass vaccination during a pandemic...- Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink studyLisa A Jackson
Group Health Research Institute, Seattle WA, USA
BMC Infect Dis 9:165. 2009..Local reactions are the most commonly reported adverse events following tetanus and diphtheria toxoid (Td) vaccine and the risk of local reactions may increase with number of prior Td vaccinations... - Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003Juliette Morgan
Centers for Disease Control and Prevention and 2Department of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA
Clin Infect Dis 46:S242-50. 2008..We describe an association between smallpox vaccination, using the US vaccinia strain, and myo/pericarditis among civilians... - Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safetyPenina Haber
Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mail Stop D 26, 1600 Clifton Rd, Atlanta, GA 30333, USA
Pediatrics 127:S39-44. 2011.... - Death and serious illness following influenza vaccination: a multidisciplinary investigationAlison Rue-Cover
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Immunization Safety Office ISO, Division of Healthcare Quality Promotion, Atlanta, GA 30333, USA
Pharmacoepidemiol Drug Saf 18:504-11. 2009..All had received vaccine from the same lot (Lot A)... - How can you promote vaccine safety?Elaine R Miller
Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, GA, USA
Nursing 37:58-63; quiz 63-4. 2007 - Tracking vaccine-safety inquiries to detect signals and monitor public concernsElaine Miller
Division of Healthcare Quality Promotion, Immunization Safety Office, Centers for Disease Control and Prevention, Mail Stop D 26, 1600 Clifton Rd, Atlanta, GA 30333, USA
Pediatrics 127:S87-91. 2011..Past inquiries to public health authorities identified potential problems including viscerotropic illness rarely associated with yellow fever vaccination... - Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccineBarbara A Slade
Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop D 26, Atlanta, GA 30333, USA
JAMA 302:750-7. 2009.... - Guillain-Barré syndrome following influenza vaccinationPenina Haber
Immunization Safety Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
JAMA 292:2478-81. 2004..Guillain-Barre syndrome remains the most frequent neurological condition reported after influenza vaccination to the Vaccine Adverse Events Reporting System (VAERS) since its inception in 1990... - Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004James J Sejvar
Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
JAMA 294:2744-50. 2005..The reinstatement of smallpox vaccination in the United States in response to possible bioterrorism renewed concerns about vaccine-related adverse neurologic events... - Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS)Lauren DiMiceli
Immunization Safety Branch, NIP CDC, Mail Stop E61, Atlanta, GA 30333, USA
Vaccine 24:703-7. 2006..Nevertheless, yeast associated anaphylaxis after HBV in sensitized patients appears to be a rare event... - Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007Penina Haber
Centers for Disease Control and Prevention, National Center for Immunizations and Respiratory Diseases, 1600 Clifton Rd, MS A 47, Atlanta, GA 30333, USA
Pediatrics 121:1206-12. 2008..Although the new rotavirus vaccine (RotaTeq; Merck, West Point, PA) introduced in 2006 was not associated with intussusception in prelicensure trials, additional monitoring is important to ensure a complete safety profile... - Tracking vaccine lot lifecycles using reports to the vaccine adverse event reporting system (VAERS)Gustavo H Dayan
Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Pharmacoepidemiol Drug Saf 14:671-6. 2005..We used data from reports to the Vaccine Adverse Event Reporting System (VAERS) to develop a proxy means of surveillance for the lifecycle of selected vaccine lots... - A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety dataJane Gidudu
Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Vaccine 26:6800-13. 2008.... - Ischemic cardiac events during the Department of Health and Human Services Smallpox Vaccination Program, 2003David L Swerdlow
Smallpox Vaccine Adverse Events Monitoring and Response Activity, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Clin Infect Dis 46:S234-41. 2008..10; 95% PI, 3.5-15.7). After persons with >/=3 cardiac risk factors or known heart disease were deferred from vaccination, no ICEs were reported among an additional 6638 vaccinees...